[Clinical evaluation of new antileukemic agent. 1) Cyclocytidine (author's transl)].
D000328:Adult; D002648:Child; D003561:Cytarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D012075:Remission, Spontaneous
D003561:Cytarabine